| Asymmetric silica nanoparticles with tunable head–tail structures enhance hemocompatibility and maturation of immune cells PL Abbaraju, AK Meka, H Song, Y Yang, M Jambhrunkar, J Zhang, C Xu, ... Journal of the American Chemical Society 139 (18), 6321-6328, 2017 | 108 | 2017 |
| Hybrid nanoreactors: Enabling an off‐the‐shelf strategy for concurrently enhanced chemo‐immunotherapy Y Yang, J Tang, PL Abbaraju, M Jambhrunkar, H Song, M Zhang, C Lei, ... Angewandte Chemie International Edition 57 (36), 11764-11769, 2018 | 107 | 2018 |
| Stepwise degradable nanocarriers enabled cascade delivery for synergistic cancer therapy Y Yang, Y Lu, PL Abbaraju, I Azimi, C Lei, J Tang, M Jambhrunkar, J Fu, ... Advanced Functional Materials 28 (28), 1800706, 2018 | 103 | 2018 |
| Rifampicin-loaded mesoporous silica nanoparticles for the treatment of intracellular infections S Subramaniam, N Thomas, H Gustafsson, M Jambhrunkar, SP Kidd, ... Antibiotics 8 (2), 39, 2019 | 48 | 2019 |
| Asymmetric mesoporous silica nanoparticles as potent and safe immunoadjuvants provoke high immune responses PL Abbaraju, M Jambhrunkar, Y Yang, Y Liu, Y Lu, C Yu Chemical communications 54 (16), 2020-2023, 2018 | 45 | 2018 |
| Poly(lactic-co-glycolic) Acid–Lipid Hybrid Microparticles Enhance the Intracellular Uptake and Antibacterial Activity of Rifampicin S Maghrebi, P Joyce, M Jambhrunkar, N Thomas, CA Prestidge ACS applied materials & interfaces 12 (7), 8030-8039, 2020 | 43 | 2020 |
| Understanding the effect of surface chemistry of mesoporous silica nanorods on their vaccine adjuvant potency Y Yang, M Jambhrunkar, PL Abbaraju, M Yu, M Zhang, C Yu Advanced healthcare materials 6 (17), 1700466, 2017 | 41 | 2017 |
| Enzyme responsive copolymer micelles enhance the anti-biofilm efficacy of the antiseptic chlorhexidine YN Albayaty, N Thomas, M Jambhrunkar, M Al-Hawwas, A Kral, CR Thorn, ... International Journal of Pharmaceutics 566, 329-341, 2019 | 31 | 2019 |
| Designed synthesis of organosilica nanoparticles for enzymatic biodiesel production M Kalantari, M Yu, M Jambhrunkar, Y Liu, Y Yang, X Huang, C Yu Materials Chemistry Frontiers 2 (7), 1334-1342, 2018 | 29 | 2018 |
| Pristine large pore benzene-bridged mesoporous organosilica nanoparticles as an adjuvant and co-delivery platform for eliciting potent antitumor immunity M Jambhrunkar, Y Yang, M Yu, M Zhang, PL Abbaraju, T Ghosh, ... Materials Today Advances 6, 100069, 2020 | 22 | 2020 |
| Pristine mesoporous carbon hollow spheres as safe adjuvants induce excellent Th2-biased immune response M Jambhrunkar, M Yu, H Zhang, P Abbaraju, AK Meka, A Cavallaro, Y Lu, ... Nano Research 11, 370-382, 2018 | 18 | 2018 |
| Engineering PLGA–lipid hybrid microparticles for enhanced macrophage uptake S Maghrebi, M Jambhrunkar, P Joyce, CA Prestidge ACS Applied Bio Materials 3 (7), 4159-4167, 2020 | 16 | 2020 |
| Mesoporous carbon hollow spheres: carbonisation-temperature-dependent delivery of therapeutic proteins T Ghosh, M Mantri, Z Gu, M Kalantari, M Yu, C Yu Journal of Materials Chemistry B 6 (5), 763-768, 2018 | 9 | 2018 |
| Targeting acute myeloid leukemia using sphingosine kinase 1 inhibitor-loaded liposomes TM Nguyen, M Jambhrunkar, SS Wong, DM Ross, P Joyce, JW Finnie, ... Molecular Pharmaceutics 20 (8), 3937-3946, 2023 | 4 | 2023 |
| Evaluation of polycaprolactone matrices for sustained intravaginal delivery of a natural macromolecular microbicide, lactoferrin M Pathak, AGA Coombes, M Jambhrunkar, D Wang, KJ Steadman Journal of Drug Delivery Science and Technology 61, 101191, 2021 | 3 | 2021 |
| Mesoporous Organosilica Nanoparticles to Fight Intracellular Staphylococcal Aureus Infections in Macrophages M Jambhrunkar, S Maghrebi, D Doddakyathanahalli, A Wignall, ... Pharmaceutics 15 (4), 1037, 2023 | 2 | 2023 |
| In-vitro antioxidant and free radical scavenging activity of Butea frondosa Roxb. flower M Mantri Pharmacognosy Journal 3 (21), 65-68, 2011 | 2 | 2011 |
| Oxidoreductase enzyme: The hope for Biotransformation M Mantri, S Jambhrunkar Pharma Times 41 (2), 13-15, 2009 | 1 | 2009 |
| Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax TM Nguyen, P Joyce, DM Ross, K Bremmell, M Jambhrunkar, SS Wong, ... Pharmaceutics 16 (2), 209, 2024 | | 2024 |
| Materials Today Advances M Jambhrunkar, Y Yang, M Yu, M Zhang, PL Abbaraju, T Ghosh, ... | | 2020 |
